Terence Loh and Nelson Loh, Co-Founders of Novena Global Healthcare, Announce Legal Separation of Business Interests

SINGAPORE, Oct 7, 2020 – (ACN Newswire) – Mr Terence Loh and Mr Nelson Loh, directors and co-founders of the Novena Global Healthcare group of companies, have entered into an agreement to legally separate all their businesses interests, Mr Terence Loh announced today.



Terence Loh, Co-founder of Novena Global Healthcare Group



Under a Separation Agreement entered into between the two cousins and former business partners on 6 October 2020,

1. Terence Loh will transfer all the shares he owns in Singapore-registered Bellagraph Nova Pte. Ltd. ("BNG (SG)") to Nelson Loh for one Singapore dollar (S$1). Thereafter, Terence Loh will resign as director of BNG (SG).
2. Nelson Loh will transfer all shares he owns in three corporate entities to Terence Loh for one Singapore dollar (S$1). Thereafter, Nelson Loh will resign as director of these three entities, namely:
– Singapore-registered Dorr Global Healthcare International Pte. Ltd.;
– Singapore-registered Rock Star Advisors Pte. Ltd.; and
– Cayman Islands-registered Novena Global Healthcare Group and all subsidiaries.

Terence Loh and Nelson Loh have agreed to complete the share transfers and resignations of directorships by 5 November 2020, provided that there are no unforeseeable difficulties. Both parties will entire into a written agreement if an extension is required.

The Separation Agreement follows recent media coverage surrounding the two former business partners, as well as police investigations into complaints by auditors Ernst & Young of forgery of financial statements.

Under the agreement, should Terence Loh discover after 6 October 2020 that he is jointly a shareholder and/or director of any other company other than the four entities cited, both he and Nelson Loh will do all that is necessary to effect a termination of such shareholding and/or directorship.

With reference to media statements relating to proposed corporate actions of the Bellagraph Nova Group, the Separation Agreement cites Nelson Loh's acknowledgement that Terence Loh, though a Director in BNG (SG), was not involved in any business decisions within BNG (SG).

Ms Evangeline Shen, speaking on behalf of the "Bellagraph Nova Group", has been quoted by the international media earlier this month that the latter was still pursuing a takeover bid of the Newcastle United Football Club, which competes in the Premier League in the United Kingdom.

"Nelson acknowledges and agrees that although Terence is a director of BNG (SG), his views and approval as a director of BNG (SG) were not sought prior to Evangeline Shen commenting to the media that the Bellagraph Nova Group was still pursuing a takeover bid in relation to Newcastle United Football Club," the Separation Agreement stated.

Nelson Loh also "acknowledges and agrees that he remains liable on all guarantees that he executed despite the separation of interests" as set out in the Separation Agreement.

Terence Loh commented: "This is a mutually agreed and legally binding document which clearly separates the business interests that Nelson and I have been involved in since 2008. We have gone through many challenges together and the time has come now for each of us to chart our separate careers and pursuits."

"This agreement provides clarity for me to resolve legal and corporate issues of the businesses transferred to me. In relation to the alleged forgery of the accounts of Novena Global Healthcare Group, I unequivocally state that I was not involved in the forgery. I have remained in Singapore and continue to be available to assist the Commercial Affairs Department ("CAD"). I do not wish to comment on the press release issued earlier today by the Bellagraph Nova Group. My focus is to do my best to preserve and enhance value for stakeholders in the corporate entities for which I am a director. The role that others have played in the current difficulties will become, in due course, clear," Terence Loh added.

Media Relations Contact:
WeR1 Consultants Pte Ltd
Whatsapp (text only): +65 9748 0688
Email: mediacontactTL@wer1.net

Copyright 2020 ACN Newswire. All rights reserved. http://www.acnnewswire.com

China Biotech Services (8037.HK) cooperates with the National Institute for Viral Disease Control and Prevention, China CDC for developing a new generation of Genetically Engineered Recombinant Vaccine

HONG KONG, Oct 5, 2020 – (ACN Newswire) – China Biotech Services (8037.HK) announced that its wholly-owned subsidiary Shenzhen Genius Biotech Services Co., Ltd. ("Shenzhen Genius") and the National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention have entered into a technology transfer agreement for cell lines of a genetically engineered recombinant candidate vaccine for the 2019 Coronavirus (COVID-19). Shenzhen Genius has the right to develop, transfer, evaluate, register and conduct clinical trials for this vaccine. Shenzhen Genius also has the right to conduct clinical research, manufacture and sell the vaccine on its own or commission other entities to conduct the aforesaid or jointly conduct the aforesaid with other entities. The company has completed the global patent registration for the vaccine.

The Cell Lines of the Genetically Engineered Recombinant Candidate Vaccine will be used for the prevention of 2019 novel coronavirus pneumonia. Related animal experiments and efficacy trials have shown the vaccine to be well tolerated with no side effects. The vaccine is a genetically engineered subunit vaccine, which removes the harmful genes of SARS-CoV2 and is considered to be the safest type of vaccine among those currently under development.

The vaccine can be manufactured commercially through genetic engineering in an ordinary GMP manufacturing plant, thus eliminating the biosafety risk of cultivating the virus. It can quickly be manufactured with a high degree of safety at a low cost with annual production capacity reaching more than 2 billion human doses at one-fourth of the cost of existing vaccine types.

The biotechnology industry plays a pivotal role in containing COVID-19 as the virus rapidly spreads throughout the world. China Biotech Services, with its international research team, is one of the top ranking companies in cell drug development and medical testing in the world. As the third COVID-19 outbreak hit Hong Kong, China Biotech Services partnered with BGI Health (HK) Company Limited to incorporate Sunrise Diagnostic Centre Limited to provide community testing services to Hong Kong citizens. Nearly 2 million samples were tested with more newly confirmed cases identified, which help to cut the chain of infection and demonstrating Sunrise Diagnostic Centre's accurate and efficient detection capabilities.

With people around the world eagerly awaiting a COVID-19 vaccine, China Biotech Services received the transfer of COVID-19 cell lines of genetically engineered recombinant candidate vaccine technology from Chinese Center for Disease Control and Prevention, providing China Biotech Services the right to conduct clinical research, manufacture and sell the vaccine on its own. China Biotech Services formally joined COVID-19 vaccine research and development in hopes of reducing the spread of the deadly virus. The company is combining its precise testing capabilities with its advantages of actively accelerating vaccine research and its development and industrial production capabilities as it jointly accelerates the development of a vaccine to combat the COVID-19 epidemic.

The Cell Lines of the Genetically Engineered Recombinant Candidate Vaccine were developed by Professor Bi Shengli's team which has years of extensive research experience in the field. Professor Bi is currently the Director of the Hepatitis Division of the National Institute for Viral Disease Control and Prevention at the Chinese Center for Disease Control and Prevention. He graduated from Tongji Medical University in 1984 and the Institute of Virology, Chinese Academy of Preventive Medicine in 1989. From 1989 to 1993, he was invited by the Centers for Disease Control and Prevention in the United States to conduct postdoctoral research. During this period, he was the first in the world to complete the gene sequencing of the human hepatitis E virus and the first Chinese researcher to complete the gene sequencing and cloning of hepatitis C virus. Professor Bi and his team will join China Biotech Services to collaborate with its team of scientists on the COVID-19 vaccine project.

China Biotech Services looks forward to working closely with Professor Bi and his team to fully promote the development and industrial production of the Cell Lines of a Genetically Engineered Recombinant Candidate Vaccine, as they fight to stop the COVID-19 epidemic. The Company is confident in the ability of the biotechnology industry to improve the quality of people's health throughout the world. China Biotech Services, committed to creating an advanced biotechnology platform, will continue to explore enhanced technology and product collaboration and acquisitions internationally, as it embraces the tremendous development opportunities within the global medical and health industry.

Copyright 2020 ACN Newswire. All rights reserved. http://www.acnnewswire.com

China Biotech Services (8037.HK) corporates with the National Institute for Viral Disease Control and Prevention, China CDC for developing a new generation of Genetically Engineered Recombinant Vaccine

HONG KONG, Oct 5, 2020 – (ACN Newswire) – China Biotech Services (8037.HK) announced that its wholly-owned subsidiary Shenzhen Genius Biotech Services Co., Ltd. ("Shenzhen Genius") and the National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention have entered into a technology transfer agreement for cell lines of a genetically engineered recombinant candidate vaccine for the 2019 Coronavirus (COVID-19). Shenzhen Genius has the right to develop, transfer, evaluate, register and conduct clinical trials for this vaccine. Shenzhen Genius also has the right to conduct clinical research, manufacture and sell the vaccine on its own or commission other entities to conduct the aforesaid or jointly conduct the aforesaid with other entities. The company has completed the global patent registration for the vaccine.

The Cell Lines of the Genetically Engineered Recombinant Candidate Vaccine will be used for the prevention of 2019 novel coronavirus pneumonia. Related animal experiments and efficacy trials have shown the vaccine to be well tolerated with no side effects. The vaccine is a genetically engineered subunit vaccine, which removes the harmful genes of SARS-CoV2 and is considered to be the safest type of vaccine among those currently under development.

The vaccine can be manufactured commercially through genetic engineering in an ordinary GMP manufacturing plant, thus eliminating the biosafety risk of cultivating the virus. It can quickly be manufactured with a high degree of safety at a low cost with annual production capacity reaching more than 2 billion human doses at one-fourth of the cost of existing vaccine types.

The biotechnology industry plays a pivotal role in containing COVID-19 as the virus rapidly spreads throughout the world. China Biotech Services, with its international research team, is one of the top ranking companies in cell drug development and medical testing in the world. As the third COVID-19 outbreak hit Hong Kong, China Biotech Services partnered with BGI Health (HK) Company Limited to incorporate Sunrise Diagnostic Centre Limited to provide community testing services to Hong Kong citizens. Nearly 2 million samples were tested with more newly confirmed cases identified, which help to cut the chain of infection and demonstrating Sunrise Diagnostic Centre's accurate and efficient detection capabilities.

With people around the world eagerly awaiting a COVID-19 vaccine, China Biotech Services received the transfer of COVID-19 cell lines of genetically engineered recombinant candidate vaccine technology from Chinese Center for Disease Control and Prevention, providing China Biotech Services the right to conduct clinical research, manufacture and sell the vaccine on its own. China Biotech Services formally joined COVID-19 vaccine research and development in hopes of reducing the spread of the deadly virus. The company is combining its precise testing capabilities with its advantages of actively accelerating vaccine research and its development and industrial production capabilities as it jointly accelerates the development of a vaccine to combat the COVID-19 epidemic.

The Cell Lines of the Genetically Engineered Recombinant Candidate Vaccine were developed by Professor Bi Shengli's team which has years of extensive research experience in the field. Professor Bi is currently the Director of the Hepatitis Division of the National Institute for Viral Disease Control and Prevention at the Chinese Center for Disease Control and Prevention. He graduated from Tongji Medical University in 1984 and the Institute of Virology, Chinese Academy of Preventive Medicine in 1989. From 1989 to 1993, he was invited by the Centers for Disease Control and Prevention in the United States to conduct postdoctoral research. During this period, he was the first in the world to complete the gene sequencing of the human hepatitis E virus and the first Chinese researcher to complete the gene sequencing and cloning of hepatitis C virus. Professor Bi and his team will join China Biotech Services to collaborate with its team of scientists on the COVID-19 vaccine project.

China Biotech Services looks forward to working closely with Professor Bi and his team to fully promote the development and industrial production of the Cell Lines of a Genetically Engineered Recombinant Candidate Vaccine, as they fight to stop the COVID-19 epidemic. The Company is confident in the ability of the biotechnology industry to improve the quality of people's health throughout the world. China Biotech Services, committed to creating an advanced biotechnology platform, will continue to explore enhanced technology and product collaboration and acquisitions internationally, as it embraces the tremendous development opportunities within the global medical and health industry.

Copyright 2020 ACN Newswire. All rights reserved. http://www.acnnewswire.com

Alaya Consulting Offers Sustainability Professional Certification Program Launched by GRI

HONG KONG, Oct 5, 2020 – (ACN Newswire) – Alaya Consulting, the leading facilitator of corporate sustainability, today announces that it has commenced accepting enrolments for the Professional Certification Program launched by Global Reporting Initiative ("GRI") today. The firm is determined to help bridge the gap between the escalating demand for sustainability professionals and the lack of recognised qualifications in the ESG reporting industry. Participants completing the program and passing the GRI Certification Online Exam will receive the accreditation of GRI Certified Sustainability Professional.



Participants of Alaya's GRI Professional Certification Program will be able to tap resources which include networking activities, industry insights, members-only webinars, etc.



Tony Wong, Founder of Alaya Consulting and GRI Nominated Trainer, stated: "The tide of ESG has been turning. The Certification Program could not have come at a better time. In the poll we conducted during our recent webinar, over 80% of the participants said there is a lack of professional certification in the industry. As the GRI Certified Training Partner in both Hong Kong and China, we are excited to offer the Certification Program which is expected to help resolve the talent drought of qualified ESG reporting professionals, and boost the reporting standards of listed companies."

The full curriculum requires obtaining a total of 5 points, including 3 points from the GRI Standards Certified Training Course, and 1 point each from two courses, namely Sustainability Reporting Process and Integrating SDGs into Corporate Reporting. Obtaining the 5 required points is the prerequisite to enrol for the GRI Certification Online Exam which supersedes the previous GRI Standards Exam. The validity of the Certification Exam expires after one year, individuals can maintain their certification status by taking the minimum learning hours.

Alaya Consulting has become a GRI Certified Training Partner in Hong Kong since 2015 and a GRI Certified Online Training Partner in China since 2020. For the past 5 years, the firm has trained members of company boards of directors, institutional investors, sustainability practitioners, financial communications professionals, graduates who aim to pursue a career in sustainability, as well as other industry practitioners.

About Alaya Consulting

Alaya Consulting, with offices in Hong Kong and Shenzhen, is a specialist consultancy focusing on ESG disclosure, pre-assurance and GRI certified training. We are the organisers of the Hong Kong ESG Reporting Awards and the first ESG advisory in Asia to receive approval from SBTi for our carbon reduction target. Facing escalating demands for climate change disclosure, Alaya has formulated a suite of climate solutions for establishing governance structure, drawing strategy, aligning with TCFD recommendations, setting up science-based targets and offering energy reduction solutions. For details, please visit here. https://www.alayaconsulting.com.hk/climate-strategy-disclosure/

Media Contact:
Alaya Consulting Limited / Alaya Consulting (Shenzhen) Limited
Regina Tai / Mia She
Tel: +852 3990 0792 / +86 755 2376 6324
Email: reginatai@alayaconsulting.com.hk / miashe@alayaconsulting.com.hk

Copyright 2020 ACN Newswire. All rights reserved. http://www.acnnewswire.com

TANAKA Develops “TRuST” Precursor for CVD/ALD Processes; Using Liquid Ruthenium Precursor to Achieve World’s Highest Vapor Pressures

TOKYO, Sep 30, 2020 – (ACN Newswire) – TANAKA Holdings Co., Ltd. (Head office: Chiyoda-ku, Tokyo; Representative Director & CEO: Koichiro Tanaka) announced today that TANAKA Kikinzoku Kogyo K.K. (Head office: Chiyoda-ku, Tokyo; Representative Director & CEO: Koichiro Tanaka), which operates the TANAKA Precious Metals manufacturing business, has developed a new liquid ruthenium precursor named "TRuST" for CVD[1] and ALD[2] processes. The vapor pressure of "TRuST" is more than 100 times higher as compared to that to previous liquid ruthenium (element symbol Ru) precursors[3], which is currently the world's highest vapor pressure value at room temperature as per TANAKA's internal evaluation.



"TRuST" precursor for CVD and ALD processes


Comparison of vapor pressure of precursor



During this precursor development, TANAKA Kikinzoku Kogyo focused on material design and synthesis research, while Professor Soo-Hyun Kim, Ph.D., School of Materials Science and Engineering, College of Engineering at Yeungnam University in South Korea, researched to optimize the film formation characteristics.

Technologies developed through this collaboration will help increase performance and reduce energy consumption for the semiconductor devices used in smartphones, computers, and the data centers where demand is to grow well into the future.

Precursors are metal-organic compounds used in chemical vapor deposition (CVD), atomic layer deposition (ALD) and other processes to form thin metal films or metal wiring on substrates. CVD and ALD processes enable the formation of films with superior step coverage on various types of base substrate. These are useful methods for forming films as semiconductors become increasingly miniaturized, with increased structural complexity, and narrower wires with every new generation.

TANAKA Kikinzoku Kogyo has developed a range of precious metal precursors over the years, including ruthenium precursors. This time, computer simulation and other techniques were used to achieve miniaturization and optimization of the molecular structure. This resulted in the successful development of a precious metal compound in a liquid form, with high vapor pressure, and thermal stability suited for film formation, all of which are important characteristics for precursors. As a result, this compound has the world's highest vapor pressure over 100 times higher than that of previous liquid ruthenium precursors. The higher the vapor pressure of precursors and the smaller their molecular structure, the higher the possible concentration of precursor in the film formation chamber, and the greater the adsorption density of precursor molecules on the substrate surface. Compared to previous precursors, this achieves excellent step coverage and improved film formation speed.

According to research carried out at Yeungnam University, ALD film formation at approximately 1.7 angstrom (A) per cycle is possible, which is the world's fastest of its type using liquid ruthenium precursor. Also, specific resistivity after film formation is approximately 13 microhm-cm, which is close to the value of bulk ruthenium metal (7.6 microhm-cm).

When bulk ruthenium is used for vapor deposition, with a temperature as high as 3000 degrees C. However, if it is converted into an organometallic compound of ruthenium precursor, it can be vaporized at low temperatures (between room temperature to 200 degrees C) under vacuum. As a result, the formation of high-quality ruthenium film with excellent step coverage at high productivity is expected. This has been an issue in the past because it is technically difficult to achieve all these characteristics at the same time. With the development of "TRuST" however, it is now possible.

Samples of Shipments of "TRuST" should begin shipping samples are planned to start in October 2020.

Background and TANAKA Kikinzoku Kogyo's development of precursor for CVD/ALD processes

In the past, the most common wiring materials used for semiconductors were copper, tungsten and cobalt. However, as semiconductors have evolved, there are increasing expectations for the precious metal ruthenium to promote further miniaturization of semiconductors because of its lower resistance and higher durability. With its superior characteristics, ruthenium is also being considered for use in transistor gate electrodes and DRAM capacitor electrodes.

The progress of technologies such as IoT, AI, and 5G over recent years has led to rapidly increasing volumes of digital data used in clouds, smartphones, and computers. Therefore, the need for even greater miniaturization of semiconductors is increasing to enable the creation of devices with higher performance and lower energy consumption. As a specialized manufacturer of precious metals, TANAKA Kikinzoku Kogyo will continue contributing to this evolution of semiconductors through the development of high-quality semiconductor materials.

With the support of Professor Soo-Hyun Kim, from the College of Engineering at Yeungnam University, a researcher from TANAKA Kikinzoku Kogyo will give a presentation of this technology at the "International Interconnect Technology Conference (IITC) 2020", which will be held online from October 5-8, 2020. The title of the presentation is High-growth-rate atomic layer deposition of high-quality Ru Using a Novel Ru metalorganic precursor.

[1] Chemical vapor deposition (CVD): CVD is a chemical film formation method. It is a method of forming thin metal films on the surfaces of base materials or substrates through a chemical reaction induced and accelerated by directing energy, in forms such as heat, plasma and light, at gaseous vapor material fed into a reaction chamber at pressures between atmospheric pressures to medium vacuum pressures (100-10-1 Pa).
[2] Atomic layer deposition (ALD): Both CVD and ALD are film formation methods that use chemical reactions inside reaction chambers to deposit material onto substrates through the vapor phase. The main difference between the two methods is that while CVD continually forms atomic and molecular layers, ALD forms the layers intermittently one layer at a time.
[3] Precursors: Precursors are compounds used as the raw material for forming thin metal films and metal wiring on substrates.

TANAKA Holdings Co., Ltd. (Holding company of TANAKA Precious Metals)
Headquarters: 22F, Tokyo Building, 2-7-3 Marunouchi, Chiyoda-ku, Tokyo
Representative: Koichiro Tanaka, Representative Director & CEO
Founded: 1885
Incorporated: 1918*
Capital: 500 million yen
Employees in consolidated group: 5,138 (FY2019)
Employees: 221 (March 31, 2020)
Net sales of consolidated group: JPY 1,149,604 million (FY2019)
Main businesses of the group: The holding company at the center of TANAKA Precious Metals responsible for strategic and efficient group management and management guidance to group companies.
URL: https://www.tanaka.co.jp/english/
* TANAKA Holdings adopted a holding company structure on April 1, 2010.

TANAKA Kikinzoku Kogyo K.K.
Headquarters: 22F, Tokyo Building, 2-7-3 Marunouchi, Chiyoda-ku, Tokyo
Representative: Koichiro Tanaka, Representative Director & CEO
Founded: 1885
Incorporated: 1918
Capital: 500 million yen
Employees: 2,393 (as of March 31, 2020)
Sales: JPY 992,679,879,000 (FY2019)
Main businesses: Manufacture, sales, import and export of precious metals (platinum, gold, silver, and others) and various types of industrial precious metals products.
URL: https://tanaka-preciousmetals.com

About TANAKA Precious Metals

Since its foundation in 1885, TANAKA Precious Metals has built a diversified range of business activities focused on precious metals. TANAKA is a leader in Japan regarding the volumes of precious metals handled. Over the course of many years, TANAKA has not only manufactured and sold precious metal products for industry but also provided precious metals in such forms as jewelry and resources. As precious metals specialists, all Group companies within and outside Japan work together with unified cooperation between manufacturing, sales, and technological aspects to offer products and services. Additionally, to make further progress in globalization, TANAKA Kikinzoku Kogyo welcomed Metalor Technologies International SA as a member of the Group in 2016.

As precious metal professionals, TANAKA Precious Metals will continue to contribute to the development of an enriching and prosperous society.

The five core companies that make up TANAKA Precious Metals are as follows.
– TANAKA Holdings Co., Ltd. (pure holding company)
– TANAKA Kikinzoku Kogyo K.K.
– TANAKA Denshi Kogyo K.K.
– Electroplating Engineers Of Japan, Limited
– TANAKA Kikinzoku Jewerly K.K.

Press release in PDF: http://www.acnnewswire.com/clientreports/598/20200930.pdf

Press Inquiries
TANAKA Holdings Co., Ltd.
https://tanaka-preciousmetals.com/en/inquiries-for-media/

Copyright 2020 ACN Newswire. All rights reserved. http://www.acnnewswire.com

WeR1’s Client SGX-Listed Sasseur REIT Wins Top IR Award For Second Consecutive Year

Singapore, 30 September 2020 – Singapore Exchange (“SGX”) Mainboard-listed Sasseur Real Estate Investment Trust (“Sasseur REIT”), a client of investor relations (“IR”) specialist WeR1 Consultants Pte Ltd (“WeR1”), has been named Platinum winner for IR at the Asia Pacific Best of the Breeds REITs Awards™ 2020. This is the second consecutive year that Sasseur REIT has secured top IR ranking, having won the Gold award in 2019.

Sasseur REIT, which has been a retained client of WeR1 since 2019, secured a total of three awards at the annual event this week. The other two are Platinum Awards for Best Retail REIT and for Best CEO – also for the second year running. All 2019 and 2020 awards received by Sasseur REIT are for REITS under U$1 billion in market value.

The Platinum IR award cited Sasseur REIT’s prompt and informative communication of information to stakeholders, media and the community. Listed in March 2018, Sasseur REIT continues to report its financial performance on a quarterly basis. It has maintained a high level of engagement through regular virtual briefings even after the outbreak of the COVID-19 pandemic.

Sasseur REIT closed its four retail outlet malls in China for several weeks in the early days of the pandemic. The closures coincided with falls in global stock markets in March 2020 and concerns about how retail REITs may be impacted by health concerns and changes to shopping trends.

After the release of Sasseur REIT’s Q1 2020 results, WeR1 worked with the management team to explain how it aligned the interests of mall owner, merchants and REIT holders. This mitigated the impact of the temporary mall closures on various stakeholders.

WeR1 worked closely with management to engage sell-side and buy-side (including remisiers serving retail investors) on Sasseur REIT’s unique ‘A x 1+N x DT’ formula which enshrines Sasseur REIT’s commitment to refresh mall concepts regularly to keep attracting foot traffic.

KGI Securities issued a fresh research report with an Outperform call, raising the number of sell-side coverage of the REIT to five. WeR1 also organised a virtual briefing between Sasseur REIT’s management and over 20 KGI brokers on 15 July 2020, as well as a webinar with Phillip Securities which attracted over 100 participants.

As a result of the efforts to explain the decisive response to the pandemic, Sasseur REIT received significant media coverage in 2020.

Bloomberg ran a commentary which mentioned how Sasseur REIT managed the landlord-tenant relationship differently. The Edge of Singapore carried an in-depth piece on this subject based on interviews with management. The coverage followed a prominent interview in 2019 of Sasseur’s founder and Chairman Mr Vito Xu who was featured in the “In Good Company” column of The Straits Times of Singapore.

Anthony Ang, CEO of Sasseur REIT, said: “We were very happy to receive the significant coverage, as well as the awards for the second consecutive year; Sasseur REIT has been working hard to achieve a swift recovery once lockdown measures in China were lifted, and a strong media strategy gave Sasseur REIT’s investors and analysts renewed confidence in our recovery.”

“We are also pleased to have WeR1 working alongside us to ensure our key differentiators were clearly and swiftly communicated, going the extra mile to offer strong media angles that were in-depth and engaging.”

Mr Lai Kwok Kin, Managing Director of WeR1, said: “The COVID-19 presented challenges as well as opportunities to position Sasseur REIT positively to the media and investment community. We are honoured to support the excellent and committed management team of Sasseur REIT, and are elated by successive awards they have secured.”

About WeR1 Consultants

WeR1 Consultants is a pan-Asian communications specialist in Investor Relations, Tech PR, Crisis Communications and Litigation PR based in Singapore. Our service is distinguished by a high level of strategy led by senior consultants with decades of experience in media, capital markets and communications. For more information on WeR1, please visit https://wer1.net/

About Sasseur REIT

Sasseur REIT is the first outlet mall REIT listed in Asia. Sasseur REIT offers investors with the unique opportunity to invest in the fast-growing retail outlet mall sector in the People’s Republic of China (the “PRC”) through its initial portfolio of four quality retail outlet mall assets strategically located in fast-growing cities in China such as Chongqing, Kunming and Hefei, with a net lettable area of 312,844 square metres.

Sasseur REIT is established with the investment strategy of investing principally, directly or indirectly, in a diversified portfolio of income-producing real estate which is used primarily for retail outlet mall purposes, as well as real estate-related assets in relation to the foregoing, with an initial focus on Asia. For more information on Sasseur REIT, please visit https://www.sasseurreit.com



Copyright 2020 ACN Newswire. All rights reserved. http://www.acnnewswire.com

WeR1’s Client SGX-Listed Sasseur REIT Wins Top IR Award For Second Consecutive Year

SINGAPORE, Sep 30, 2020 – (ACN Newswire) – Singapore Exchange ("SGX") Mainboard-listed Sasseur Real Estate Investment Trust ("Sasseur REIT"), a client of investor relations ("IR") specialist WeR1 Consultants Pte Ltd ("WeR1"), has been named Platinum winner for IR at the Asia Pacific Best of the Breeds REITs Awards(TM) 2020. This is the second consecutive year that Sasseur REIT has secured top IR ranking, having won the Gold award in 2019.

Sasseur REIT, which has been a retained client of WeR1 since 2019, secured a total of three awards at the annual event this week. The other two are Platinum Awards for Best Retail REIT and for Best CEO – also for the second year running. All 2019 and 2020 awards received by Sasseur REIT are for REITS under U$1 billion in market value.

The Platinum IR award cited Sasseur REIT's prompt and informative communication of information to stakeholders, media and the community. Listed in March 2018, Sasseur REIT continues to report its financial performance on a quarterly basis. It has maintained a high level of engagement through regular virtual briefings even after the outbreak of the COVID-19 pandemic.

Sasseur REIT closed its four retail outlet malls in China for several weeks in the early days of the pandemic. The closures coincided with falls in global stock markets in March 2020 and concerns about how retail REITs may be impacted by health concerns and changes to shopping trends.

After the release of Sasseur REIT's Q1 2020 results, WeR1 worked with the management team to explain how it aligned the interests of mall owner, merchants and REIT holders. This mitigated the impact of the temporary mall closures on various stakeholders.

WeR1 worked closely with management to engage sell-side and buy-side (including remisiers serving retail investors) on Sasseur REIT's unique 'A x 1+N x DT' formula which enshrines Sasseur REIT's commitment to refresh mall concepts regularly to keep attracting foot traffic.

KGI Securities issued a fresh research report with an Outperform call, raising the number of sell-side coverage of the REIT to five. WeR1 also organised a virtual briefing between Sasseur REIT's management and over 20 KGI brokers on 15 July 2020, as well as a webinar with Phillip Securities which attracted over 100 participants.

As a result of the efforts to explain the decisive response to the pandemic, Sasseur REIT received significant media coverage in 2020.

Bloomberg ran a commentary which mentioned how Sasseur REIT managed the landlord-tenant relationship differently. The Edge of Singapore carried an in-depth piece on this subject based on interviews with management. The coverage followed a prominent interview in 2019 of Sasseur's founder and Chairman Mr Vito Xu who was featured in the "In Good Company" column of The Straits Times of Singapore.

Anthony Ang, CEO of Sasseur REIT, said: "We were very happy to receive the significant coverage, as well as the awards for the second consecutive year; Sasseur REIT has been working hard to achieve a swift recovery once lockdown measures in China were lifted, and a strong media strategy gave Sasseur REIT's investors and analysts renewed confidence in our recovery."

"We are also pleased to have WeR1 working alongside us to ensure our key differentiators were clearly and swiftly communicated, going the extra mile to offer strong media angles that were in-depth and engaging."

Mr Lai Kwok Kin, Managing Director of WeR1, said: "The COVID-19 presented challenges as well as opportunities to position Sasseur REIT positively to the media and investment community. We are honoured to support the excellent and committed management team of Sasseur REIT, and are elated by successive awards they have secured."

About WeR1 Consultants

WeR1 Consultants is a pan-Asian communications specialist in Investor Relations, Tech PR, Crisis Communications and Litigation PR based in Singapore. Our service is distinguished by a high level of strategy led by senior consultants with decades of experience in media, capital markets and communications. For more information on WeR1, please visit https://wer1.net/

About Sasseur REIT

Sasseur REIT is the first outlet mall REIT listed in Asia. Sasseur REIT offers investors with the unique opportunity to invest in the fast-growing retail outlet mall sector in the People's Republic of China (the "PRC") through its initial portfolio of four quality retail outlet mall assets strategically located in fast-growing cities in China such as Chongqing, Kunming and Hefei, with a net lettable area of 312,844 square metres.

Sasseur REIT is established with the investment strategy of investing principally, directly or indirectly, in a diversified portfolio of income-producing real estate which is used primarily for retail outlet mall purposes, as well as real estate-related assets in relation to the foregoing, with an initial focus on Asia. For more information on Sasseur REIT, please visit https://www.sasseurreit.com

Copyright 2020 ACN Newswire. All rights reserved. http://www.acnnewswire.com

Technoglobal Introduces AutoBio Inc. as Strategic Advisor Well Prepared for Listing in Hong Kong

HONG KONG, Sep 29, 2020 – (ACN Newswire) – Technoglobal Inc. ("Technoglobal" or the "Group"), a leading provider of fingerprint authentication technologies, is pleased to announce that the Group has entered into an agreement with AutoBio Inc. ("AutoBio"). The specialist in AI biomedical robotic systems will provide JPY2 billion which will assist the Group in implementing its plan to list on The Stock Exchange of Hong Kong Limited.



Mr Taketoshi Kashiwabara, President & CEO of Technoglobal



With more than two decades of excellence in AI biometric authentication technology, Technoglobal remains steadfastly committed to achieving its mission of 'supporting strong security' by providing an advanced AI biometric authentication system that enables companies and organisations to have strong security while conducting different tasks. In view of the increasing demand for AI biometric authentication systems, the Group develops and offers a comprehensive range of products that recognises and distinguishes personal characteristics, such as veins, palm, fingerprint, face, etc. Such products are also a reflection of the Group's response to the diversification of online applications and digitalisation of various services.

Incorporated in Japan, AutoBio is a medical system service provider that aims to provide state-of-the-art medical AI robotic systems which enable dexterous mechanical hands to perform accurate biomedical tasks as well as AI diagnostic imaging capabilities.

Mr Taketoshi Kashiwabara, President & CEO of Technoglobal, said: "The demand for AI biometric authentication systems has been growing rapidly in recent years. We believe that now is the best time for Technoglobal to expand its presence across Asia, Europe and the Middle East. Having an integrated network of institutions and markets, Hong Kong is well recognised as one of the world's premier international financial centre. By leveraging this capital market and with the financial support from AutoBio, including its expertise in AI robotic systems, we are confident that getting listed in Hong Kong will accelerate the Group's expansion plan in the biometric authentication industry as well as enable us to reap operational synergies with AutoBio. The Group's aim is to develop more innovative AI biometric authentication systems that will ultimately lead to the advancement of society as a whole."

About Technoglobal Inc.
Technoglobal Inc. is a fingerprint authentication provider based in Tokyo, Japan. The company commenced operation in 1995. Renowned for its sophisticated manufacturing capabilities and sales of fingerprint-related systems as well as development and consultation on authentication systems, the company continues to receive praise for its integrity and commitment to fingerprint authentication development. For further details, please visit http://www.technoglobal.co.jp



Copyright 2020 ACN Newswire. All rights reserved. http://www.acnnewswire.com

Technoglobal Introduces AutoBio Inc. as Strategic Advisor Well Prepared for Listing in Hong Kong

HONG KONG, Sep 29, 2020 – (ACN Newswire) – Technoglobal Inc. ("Technoglobal" or the "Group"), a leading provider of fingerprint authentication technologies, is pleased to announce that the Group has entered into an agreement with AutoBio Inc. ("AutoBio"). The specialist in AI biomedical robotic systems will provide JPY2 billion which will assist the Group in implementing its plan to list on The Stock Exchange of Hong Kong Limited.



Mr Taketoshi Kashiwabara, President & CEO of Technoglobal



With more than two decades of excellence in AI biometric authentication technology, Technoglobal remains steadfastly committed to achieving its mission of 'supporting strong security' by providing an advanced AI biometric authentication system that enables companies and organisations to have strong security while conducting different tasks. In view of the increasing demand for AI biometric authentication systems, the Group develops and offers a comprehensive range of products that recognises and distinguishes personal characteristics, such as veins, palm, fingerprint, face, etc. Such products are also a reflection of the Group's response to the diversification of online applications and digitalisation of various services.

Incorporated in Japan, AutoBio is a medical system service provider that aims to provide state-of-the-art medical AI robotic systems which enable dexterous mechanical hands to perform accurate biomedical tasks as well as AI diagnostic imaging capabilities.

Mr Taketoshi Kashiwabara, President & CEO of Technoglobal, said: "The demand for AI biometric authentication systems has been growing rapidly in recent years. We believe that now is the best time for Technoglobal to expand its presence across Asia, Europe and the Middle East. Having an integrated network of institutions and markets, Hong Kong is well recognised as one of the world's premier international financial centre. By leveraging this capital market and with the financial support from AutoBio, including its expertise in AI robotic systems, we are confident that getting listed in Hong Kong will accelerate the Group's expansion plan in the biometric authentication industry as well as enable us to reap operational synergies with AutoBio. The Group's aim is to develop more innovative AI biometric authentication systems that will ultimately lead to the advancement of society as a whole."

About Technoglobal Inc.
Technoglobal Inc. is a fingerprint authentication provider based in Tokyo, Japan. The company commenced operation in 1995. Renowned for its sophisticated manufacturing capabilities and sales of fingerprint-related systems as well as development and consultation on authentication systems, the company continues to receive praise for its integrity and commitment to fingerprint authentication development. For further details, please visit http://www.technoglobal.co.jp


Copyright 2020 ACN Newswire. All rights reserved. http://www.acnnewswire.com

China Nature Energy Technology Holdings Limited Announces Details of Proposed Main Board listing on SEHK

HONG KONG, Sep 29, 2020 – (ACN Newswire) – China Nature Energy Technology Holdings Limited ("CNE" or the "Group"), a wind power and pitch control system solution provider in the PRC ranked third in the domestic pitch control system market, announced the details of its proposed listing on the Main Board of The Stock Exchange of Hong Kong Limited ("SEHK"). The Group primarily engages in R&D, integration, manufacture and sale of high-voltage pitch control systems for wind turbines, and offers customised integration services of major components of pitch control systems. Pitch control system is a critical electrical system in a wind turbine for real-time regulation of the wind turbine generator's rotational speed against the changing wind velocity through control of the blade angle for optimal energy capture and minimisation of potential damages against exceedingly high speed winds. Its major customers include wind turbine manufacturers and local power grid company in Inner Mongolia.

Offering Details

CNE intends to offer a total of 62,500,000 shares (subject to over-allotment option), of which 56,250,000 shares are for international placing (subject to reallocation and over-allotment option) and 6,250,000 shares are for Hong Kong public offer (subject to reallocation). Indicative Offer Price range is between HK$2.0 and HK$2.6. Excluding the underwriting fee and estimated expenses of share offer, and assuming the over-allotment option is not exercised and the offer price is HK$2.3 per share (being the mid-point of the indicative offer price range), net proceeds from the listing are estimated at approximately HK$111.5 million.

The Hong Kong public offer will commence on 29 September 2020 (Tuesday) at 9:00 a.m. and will end at noon on 8 October 2020 (Thursday). The final offer price and allotment results are expected to be announced on 19 October 2020 (Monday) and dealing of its shares is expected to commence on the Main Board of SEHK on 20 October 2020 (Tuesday). Shares will be traded in board lots of 1,000 shares each under the stock code 1597.

Fortune Financial Capital Limited is the sole sponsor. Essence International Securities (Hong Kong) Limited, Fortune (HK) Securities Limited and Guosen Securities (HK) Capital Company Limited are the joint global coordinators, joint bookrunners and joint lead managers of the listing.

Investment Highlights

One of five largest pitch control system providers in the PRC
As one of the pioneers who has realised the integration of hardware and software to offer high-voltage pitch control systems in the PRC market, CNE has been focusing on R&D on software and integration techniques for pitch control systems since 2016. As a result of its strategic focus on the development of pitch control systems, it was its primary business segment during the track record period, attributing to the majority of its revenue. According to the F&S Report, the total market size of pitch control system in the PRC was about RMB1,834.2 million in terms of sales value in 2018, among which, sales value for high-voltage pitch control systems was around RMB1,104.4 million, representing about 60.2% of the market. CNE ranked third in the pitch control system market in the PRC in terms of sales volume in 2018 with a market share of 10.5%.

Established long-term stable relationship with upstream and downstream of the value chain
The Group collaborate with KEB Group to work on the design and integration of the software and KEB Group's hardware to produce high-voltage pitch control systems that can appeal to the needs of customers. The Group has brought KEB Group to the domestic pitch control system market and established a stable and entrusted relationship with them for product offering since 2017. The Group further entered a binding ten-year framework agreement with KEB Shanghai in December 2019.

Since 2016, CNE has started manufacturing pitch control systems for Envision Group , a famous wind turbine manufacturer and wind farm operator in the world. The Group assisted Envision Group to realise its production of wind turbines in the PRC equipped with intelligent control, advanced measurement method, expert data analysis system, active performance control and reliability-based deterministic turbines, enabling its wind turbines to function at its optimal working condition for maximum power generation and long service life in an efficient manner. The Group entered a binding ten-year framework agreement with Jiangyin Envision in December 2019.

R&D and design capabilities
The Group's R&D efforts focus on integration techniques, and it has strived to R&D on different aspects of pitch control systems, in order to produce quality and reliable pitch control systems. It is also devoted to developing and updating software programmes to collect and diagnose data in order to control the blade angle for regulating the wind turbine generator's rotational speed when wind velocity changes, for optimal energy capture and minimisation of potential damages against exceedingly high speed winds. In addition, it develops simulation master control system software for function testing for its pitch control systems.

In July 2017, its R&D centre in Jiangyin City, Jiangsu Province was recognised as one of the Jiangyin Engineering and Technology R&D Centre Projects approved by Jiangyin Science and Technology Bureau. In November 2018, the Group was recognised as a National New High-tech Enterprise for continuous R&D and transformative technology developments, leading to the formation of independent core intellectual property rights in one of the supported high-tech fields (such as renewable energy and energy conservation technologies) by the relevant authorities in the PRC.

As of 20 September 2020, the Group owned more than 25 patents and had 15 patents under application, as well as 10 software copyrights, relating to pitch control systems and wind energy related inventions and designs.

Strong production capabilities with comprehensive quality assurance
To ensure high quality control and improve its competitiveness, it set up its own production plant with approximately 900 square meters in Jiangyin City, Jiangsu Province in 2016, and then relocated its production plant with total gross area of 3,530 square meters for expansion of its production capacity in 2018. As of 20 September 2020, it was equipped with four quality testing machines in its streamlined production line with annual capacity of 2,408 sets of pitch control systems, enabling it to implement stringent quality control measures from material inspection to examination of finished products, and comply with required standards, and then all products can proceed to the next stage of the assembling process or be packaged for delivery. Its quality control system has complied with the standard of GB/T 19001-2016/ISO9001: 2015 Quality Management Systems Requirements, and has been awarded a certificate for the design and manufacture of pitch control systems.

Experienced, stable and dedicated management team
The Group is managed by an experienced core management team, and has established a good business network with both upstream and downstream industry players along the wind power industry value chain. Under the leadership of an experienced leader, its R&D team has produced various customised high-voltage pitch control systems for customers, registered various pitch control related patents and software copyrights, and the Group was recognised as a National New High-tech Enterprise in 2018.

Future Growth Strategies

According to F&S Report, there is sufficient long-term and sustainable market demand in the wind power industry in the PRC. The Group has strived to achieve sustainable growth and further strengthen its market position in the pitch control system related manufacturing and sales business, expand its wind power generation business and continue to diversify and expand its wind power related services offerings, in order to maintain and increase long-term shareholder value and create maximum customer value. To achieve this, it will continue to actively seek for business opportunities in the wind power industry by implementing the following business strategies.

Maintains and strengthens position in pitch control system market to grow market share in the PRC
As a pitch control system supplier, demand for the Group's business is mainly driven by the sustainable demand from the wind turbine industry. The Chinese Government has recently initiated the promotion of healthy and sustainable development of wind power industry and such initiative is expected to stimulate a large number of enterprises to complete the construction of wind power projects in advance before the end of 2021 to enjoy the preferential policy, hence drive the demand for wind turbines and pitch control systems. The higher energy production efficiency and lower rate of malfunctions of high-voltage pitch control systems will help wind farms save operating costs in the long run, hence Frost & Sullivan also expects stronger demand for high-voltage pitch control systems in the long term. The share percentage of the PRC's pitch control system market is expected to increase from 63.0% in 2018 to 96.0% in 2023.

Drawing on its capability to offer high-voltage pitch control for offshore wind power projects, the Group plans to increase its market share in the expanding offshore wind power market. In addition, the Group seeks to maintain stable relations with its existing key client Envision Group and has entered a binding ten-year framework agreement with Jiangyin Envision. Given its extensive industry experience and a management team with strong servicing capabilities, the Group will continue to provide after-sales and value-added services which are tailored to customers' specific needs so as to maintain existing customer base, drive sales amount and enlarge its market share in the PRC.

Expands customer base
Regarding the pitch control system related manufacturing and sales business, other than Envision Group which is the Group's largest customer, the Group has also built business relations and entered a strategic cooperative agreement with Shanghai Electric as well as signed a sales agreement with Zhejiang Windey . Furthermore, the Group was awarded a tender for the supply of 120 sets of pitch control systems with a total contract sum of approximately RMB23.8 million. The Group will (i) develop and manufacture pitch control system prototypes for potential clients to demonstrate the quality and functionalities of its products and introduce new models or designs to potential customers and collect feedbacks; (ii) participate in various exhibitions in the wind power industry to promote the R&D involved in its products and services; and (iii) recruit additional sales personnel to establish and strengthen business relations with potential customers.

In view of the bright prospect of distributed wind farm business, the Group made strategic investments involving the interest in Datong Fengyuan and Datong Fengze in 2019. The Directors believe (i) the wind farm operation business will become a stable income source for the Group; (ii) the participation in the PRC's distributed wind farm operation business will enable the Group to diversify its customer base; and (iii) the operation of the Group's own distributed wind farms would enable it to draw on its experience in pitch control systems and operation and maintenance services to provide better services to customers and enhance its reputation in the PRC's wind power industry.

As for the wind farm operation and maintenance services business, the Group entered an agreement with Shandong Runhai Wind Power Development Co., Ltd. in March 2020 relating to the upgrade and modification of pitch control systems with a total contract sum of approximately RMB3.5 million. Looking ahead, the Group will continue to strive for the expansion of each of the add-on offerings, in particular the maintenance service and upgrade and modification works. By utilising its R&D function and with the support of experienced staff who have diverse skillsets within the wind power industry, the Group will explore the possibility of expanding its maintenance services and upgrade and also modification works to other components of wind turbines. In addition, the Group intends to recruit additional service personnel aiming to expand the scale of its wind farm operation and maintenance services.

Further strengthens R&D capability to enrich solution offering
The Group strives to provide products featuring comprehensive functions and advanced technologies at competitive prices. Apart from developing and updating software programmes to collect and diagnose data for optimal energy capture and minimisation of potential damages against exceedingly high speed winds, it has also developed simulation master control system software used for function tests of pitch control systems. The Group plans to (i) acquire additional software and testing machines for testing used in the R&D process to facilitate efficient and cost effective quality testing process while reducing the need and cost of using external testing labs; (ii) expand technical and R&D team by recruiting 13 additional personnel to serve the needs of customers in onshore and offshore wind power projects; and (iii) develop the integration technique and software for pitch drive controllers supplied by a supplier, which is specialised in the R&D and production of pitch drive controllers, frequency conversion control products, energy storage products and visual inspection system, and commercially viable pitch control systems to enhance its R&D capability and enrich its solution portfolio.

Use of net proceeds
Assuming the over-allotment option is not exercised and the offer price is fixed at HK$2.30 per share, being the mid-point of the indicative offer price range between HK$2.00 and HK$2.60 per share, net proceeds from the global offering (after deducting underwriting fees and estimated expenses in connection with the global offering) will be HK$111.5 million. The Group intends to use the net proceeds as follows:

Usage / Percentage
Purchase of core components and raw materials necessary for the production of customised high-voltage pitch control systems to fulfil the expected purchase quantities of Jiangyin Envision under the binding ten-year framework agreement: 18.7%
Diversify customer base in the pitch control system market by increasing marketing efforts: 3.6%
Invest in the development of a new distributed wind farm by Lingqiu Fengyuan in Lingqiu County in Datong of Shanxi Province: 31.2%
Recruit 70 additional service personnel to expand wind farm operation and maintenance services: 3.8%
Further strengthen R&D capability to enrich pitch control system and solution offerings: 11.4%
Repay in full a loan due to a third party by Duolun Wind Farm: 21.3%
General working capital: 10.0%

Financial Performance

RMB'000 For the year ended 31 December For the four months ended 30 April
2017 2018 2019 2019(unaudited) 2020
Turnover 57,314 144,424 222,835 36,936 51,482
Gross profit 18,871 44,503 66,397 12,125 13,395
Gross profit margin 32.9% 30.8% 29.8% 32.8% 26.0%
Profit for the year/period 7,699 27,875 42,689 7,067 4,236

China Nature Energy Technology Holdings Limited
China Nature Energy Technology Holdings Limited is a wind power and pitch control system solution provider in the PRC. The Group primarily engages in R&D, integration, manufacture and sale of high-voltage pitch control systems for wind turbines and also offers customised integration services of major components of pitch control systems. In 2018, it ranked third in the pitch control system market in the PRC in terms of sales volume.


Copyright 2020 ACN Newswire. All rights reserved. http://www.acnnewswire.com